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Objective: The aim of this study was to investigate whether a long proximal oesophageal resection 
margin is associated with improved survival after oesophagectomy for cancer and to identify the 
optimal margin to aim for in patients undergoing oesophagectomy for malignant disease.     
Methods: A prospectively maintained database identified 174 patients who underwent Ivor-Lewis 
oesophagectomy for cancer. Demographic, clinical and pathological data were collected.   The 
proximal Resection Margin (PRM) was obtained from pathology reports.  Electronic patient records 
were interrogated to calculate Disease Free Survival (DFS) and Overall Survival (OS).  X-tile software 
was used to identify the optimal resection point. Two models were analysed: single point resection 
requiring comparison of two groups (‘short’ and ‘long’) and two resection points requiring 3 groups 
(‘short’, ‘medium’ and ‘long’) to provide a range. Survival analysis was performed using Kaplan-
Meier curves and Cox Proportional Hazards (PH) model.  
Results:  The median PRM was 4.0cm (inter-quartile range: 2.5cm to 6.0cm).  The length of PRM was 
adjusted for significant confounders noted on univariable analysis (adjuvant treatment, grade of 
disease, age at diagnosis and recurrence) in the multivariable Cox PH model.  In the two group 
analysis (‘short’ and ‘long’), the optimal resection margin was 1.7cm and in the three group analysis 
the optimum PRM was between 1.7 and 3cm  (‘medium’ group). 
 In the two group analysis, the ‘long’ margin had no effect on DFS (p=0.37), but carried a significantly 
improved OS (HR=0.46, 95%CI: 0.25-0.87, p=0.02).  In the three group analysis, DFS was the same in 
all 3 groups, but the ‘medium’ and’ ‘long’ groups had improved OS compared to the ‘short’ group 
(on average 54%, HR≥0.45, p≤0.04). Further analysis demonstrated that the optimal PRM is between 
1.7 and 3cm irrespective of confounding variables. The 5-year DFS and OS rates were highest in the 
‘medium’ PRM group (48% and 57% respectively).  
Conclusion:  Optimal survival following oesophagectomy for cancer is achieved with a PRM of 
greater than 1.7cm, but a PRM of >3cm does not yield a further survival advantage.  Thus, the 




Oesophageal cancer remains a devastating disease, with an increasing incidence worldwide, 
particularly in Western countries.1,2  Although multi-modality treatment has improved outcomes 
over the last decade, early diagnosis and surgical resection remain the mainstay of curative 
treatment.3  However, an oesophagectomy has significant risks, with mortality reported between 1-
23%.4  Local recurrence after surgery can cause distressing symptoms, with death ensuing soon 
after.  A key prognostic factor affecting local recurrence and long-term survival is tumour 
involvement at the resection margins.5-7 
The importance of a negative circumferential resection margin has been well-established for many 
cancers, including oesophageal cancer.8,9  However, there have  been  few studies on the importance 
of the proximal resection margin (PRM).10-15  The first study specifically assessing this was by Miller in 
1962, which recommended a 12cm proximal resection margin to achieve adequate clearance.  This 
was based on the observation of microscopic skip lesions of tumour along the oesophagus, thought 
to be running in intra-mural lymphatics.10  Further work by Skinner elaborated on this 
recommendation, and advocated a 10cm margin.11 In contemporary practise,  a margin of 4-6cm is 
commonly employed. The critical step in an oesophagectomy is fashioning a gastro-oesophageal 
anastomosis.  The most debilitating complication of the operation, which can cause death, is an 
anastomotic leak.  A more proximal anastomosis may be associated with a higher leak rate, with its 
associated morbidity and mortality.16-18 This is thought to relate to the blood supply and tension at 
the anastomosis . 
The aim of this study was to examine the implications of the length of the proximal resection margin 
in patients undergoing  oesophagectomy, in terms of disease free and overall survival and  to 




A prospectively maintained database was searched and patient details on all oesophagectomies 
performed between November 2000 and January 2011 were retrieved.  Further clinical information 
was obtained from patients’ records.   
A total of 213 consecutive cases were identified. Patients who had  oesophagectomy for benign 
disease or transhiatal surgery were excluded.  Patients who had a histologically confirmed diagnosis 
of malignancy of the oesophagus or gastro-oesophageal junction (Siewert type 1)19 who required an 
oesophagctomy, were included.  All  cases were discussed at a multi-disciplinary meeting, where 
neo-adjuvant, surgical and adjuvant  treatment proposals were agreed.  All surgery was performed 
by specialist oncological gastro-oesophageal surgeons, and histopathology reported by specialist 
gastro-intestinal pathologists.   Ivor-Lewis oesophagectomy involves a two-compartment approach 
with either a laparotomy or laparoscopy and a right thoracotomy to mobilise the stomach, resect the 
oesophagus and fashion the gastro-oesophageal anastomosis.  The oesophageal resection was 
associated with a two-field nodal resection.  The operating surgeon would aim for a macroscopic 
5cm resection margin from the tumour. A cuff of crura was resected in continuity with the tumour, 
and meso-oesophageal tissue was excised to the aorta and azygos vein, including all peri-
oesophageal nodes and the thoracic duct en bloc. 
Following exclusion, a total of 174 cases were included in the study.  Clinicopathological features of 
each case were analysed.  Staging was assigned according to the Tumour Node Metastases (TNM) 
classification system.20,21   Follow-up data were collected from patient’s records.  Recurrence was 
defined as either pathological or radiological evidence of disease after surgery.  Patients were 
followed up at 3 monthly intervals for the first year, 6 monthly for the second year and annually 
thereafter.  Computerised tomography (CT) and endoscopy was performed for patients with 
symptoms suggestive of recurrence, but routine surveillance investigations were not performed.  All 
references to PRM are microscopic descriptions based on measurements of the formalin fixed 
specimen.   
 
Statistical Analysis 
Distribution of the Proximal Resection Margins (PRM) was assessed with Notched Box-and-whisker 
plots.  Overall survival (OS) was measured from date of surgery to death or last follow-up, and 
disease-free survival (DFS) was from date of surgery to confirmed diagnosis of local or distant 
recurrence.  Kaplan–Meier plots were used to analyse DFS and OS, with corresponding log rank 
tests.22  Univariable analysis was performed for all factors using the Cox Proportional Hazards (PH) 
model, with multivariable analysis performed for PRM including and adjusting for the significant 
patient and tumour factors found in univariable analysis for each outcome measure.  
Categorical data analysis involved the assessment of the optimal PRM for factors without validated 
normal ranges.  This was performed using the X-Tile statistical package (X-Tile version 3.6.1 Yale 
University 2003-05, New Haven, CT).23  This enables specific resection margins to be evaluated in 
order to ascertain whether the resected length had any effect on survival.  The X-Tile software 
divides the cohort (n=174) into two independent data sets—a test set and a validation set—in a 1:2 
ratio.  It then determines the optimal resection margin length as a factor for the test set, and applies 
this to the validation set.  
The proportional hazards assumption for each predictor in the final models was assessed using 
scaled Schoenfeld residuals.  This assumption was not rejected in any of the models.  Statistical 
analyses were performed using statistical software package Intercooled STATA 12.0 (Stata Corp, 






Patient and Tumour Factors 
The median age at diagnosis was 64 years (Inter-Quartile Range: 58-70), see, Table 1.  Of the 174 
patients included in this study, 137 (78.7%) were male.  The vast majority of the tumours were 
adenocarcinoma (90.8%), with 8.6% squamous cell carcinoma and one small cell carcinoma.  Most of 
the tumours were oesophageal in origin (89%), with the remainder arising from the gastro-
oesophageal junction (Siewert 1). The majority of patients received neo-adjuvant chemotherapy 
(78.7%) as advised by the multidisciplinary team. Sixty-two percent had a laparoscopic gastric 
mobilisation and 38% underwent an open approach.   
On histopathological analysis of the resected specimen, 63.2% were Grade 3, 29.9% grade 2 and 
6.9% Grade 1.  The pathological TNM stage distribution was T3 in 58.6%, T2 in 21.2%,  T1 in 19% and 
one patient was Stage T4 (1.2%). The nodal status was negative in 40.2%, N1 in 43.2% with the 
remainder N2.  Lymphovascular invasion was present in 44.8% of cases and perineural invasion in 
34.4%.    
Thirty six (20.6%) patients received post-operative chemotherapy, and 26 (15%) received adjuvant 
radiotherapy.  Univariable analysis, using Cox’s PH model, demonstrated that DFS was significantly 
dependent on adjuvant treatment and the grade of the disease while OS was significantly dependent 
on adjuvant treatment, grade of disease, age at diagnosis and recurrence. Table 1 demonstrates the 
key patient and tumour characteristics.   
Median follow-up was 19.6 months (Range 1-124 months ).  Sixteen patients were lost to complete 
follow-up, but their data has been included on an intention to treat basis.  
Complications and Surgical Outcomes 
Six patients died within thirty days of surgery (one from anastomotic leak, four from respiratory 
complications and one from cardiovascular disease).  The anastomotic leak rates were similar in the 
‘short’, ‘medium’ and ‘long’ groups (8.7%, 7.9% and 8.8% respectively).  The rate of post-operative 
pulmonary complications was highest in the ‘long’ PRM group (24.8%) compared to the ‘short’ and 
‘medium’ group (17.4 and 18.4% respectively).   
Resection Margin 
Four patients had an involved PRM, constituting 2.3% of all patients.  Six patients (3.4%) had an 
involved distal margin and nine patients (5.2%) had a positive circumferential margin.  Three 
patients had two or more involved margins, all of which were T3 tumours.   
The median microscopic PRM was 4cm, with a range of 0 to 12cm (Figure 1).  The greatest number 
of these lay between 2.5 and 6cm (n=98; 56%).  As a continuous co-variate, the PRM was not 
significantly predictive of either disease free (p=0.84) or overall survival (p=0.63) on univariable 
analysis.  
We documented anastomotic recurrence in 4 patients (2.3%) of whom three patients had an 
involved or <1mm margin (1 PRM, and 2 circumferential margins). Two of these patients were 
concurrently found to have disseminated metastatic disease and two had extensive nodal 
recurrence. 
Risk Factors Number of patients (%) 
  
Age (years) Median 64, IQR: 58-70 
  
Sex 
   Male 






   SCC* 
   Adenocarcinoma 







   Oesophageal 
   Gastro-Oesophageal Junction 






   I 
   II 







   T1 
   T2 
   T3 









   N0 
   N1 
   N2 








   M0 





Lymphovascular Invasion 78 (44.8) 
Perineural Invasion 60 (34.4) 
  
Surgery 
   Laparoscopic Ivor-Lewis 






   Chemotherapy 










   Radiotherapy 26 (15) 
Table 1. Patient and Tumour Characteristics *SCC- Squamous Cell Carcinoma; †Based TNM Classification20,21 
 
Figure 1. Notched Box-and-whisker plot distribution of proximal resection margins 
 
 
The Optimal Proximal Resection Margin (PRM) 
The optimal PRM was determined to be between 1.7cm and 3cm, based on analysis of outcome 
measures for the 174 patients, adjusted for the significant confounding variables (adjuvant 
treatment, grade of disease, age at diagnosis and recurrence).   
The statistical software utilised to determine the optimum resection margin involved a division of 
the study population into a test and validated cohort in a 1:2 ratio, thereby allowing both an analysis 
and application to the continuous data.  The purpose of this analysis was to establish an optimal 
PRM.  At this optimal resection margin, any further proximal resection would not improve survival, 
but a shorter resection margin would confer a disadvantage.  The X-Tile software used for this 
analysis was performed twice for each of the two outcomes (DFS and OS): once with a single 
resection point (and thus 2 groups) and secondly with two resection points (and thus 3 groups), the 
latter to give a range rather than a single optimal PRM. 
In the two group analysis, the optimal resection margin was identified as 1.7cm ( ‘short’ n=21 versus 
‘long’ n=153) for both DFS and OS.  In, the three groups analysis, the margin was determined as a 
‘short’ resection margin of less than 1.7cm (n=21), a ‘medium’ resection margin of between 1.7cm 
and 3cm (n=38) and a ‘long’ margin of greater than 3cm (n=115) for both outcome measures (Table 
2).  
       2 Group analysis                                     n         3 Group analysis                                   n 
Short (<1.7cm) 21 Short (<1.7cm) 21 
 Medium (1.7cm - ≤3 cm) 38 
Long (≥1.7cm) 153 Long (≥3cm) 115 
Table 2. The number of patients in each group according to their proximal resection margin in both the 2 
group and 3 group analysis. 
 
 
The Kaplan-Meier survival curves, with associated log-rank test for the two group analysis (Figure 2(i) 
and (ii)) did not demonstrate a significant difference in disease free or overall survival between the 
two groups.  In the three group analysis (Figure 2(iii) and (iv)),the curves illustrate that for both DFS 
and OS, the ‘medium’ PRM group had improved survival compared to both the ‘short’ and  ‘long’ 
group.  This indicates that a longer PRM of more than 3cm may not confer a greater survival 
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Figure 2. Kaplan-Meier curves for (i) Disease-free survival based on optimal resection point of Short<1.7cm 
and Long≥1.7cm; (ii) Overall survival based on optimal resection point of Short<1.7cm and Long≥1.7cm; (iii) 
Disease-free survival based on optimal resection points of Short<1.7cm, Medium  1.7cm to ≤3.0cm and 
Long>3.0cm; and (iv) Overall survival based on optimal resection points of Short<1.7cm, Medium  1.7cm to 
≤3.0cm and Long>3.0cm. 
 
In the multivariable Cox PH model (Table 3), the optimal PRM was adjusted for the confounding 
effects of the statistically significant factors noted in the univariable analysis. In the two group 
analysis, the ‘long’ margin had no significant effect on disease free survival (p=0.37), but a significant 
effect on overall survival (HR=0.46, 95%CI: 0.25-0.87, p=0.02).  In the three group analysis, disease 
free survival did not vary significantly in terms of PRM, but the ‘medium’ and ‘long’ groups had a 
statistically significant higher chance of overall survival, on average 54% (HR≥0.45, p≤0.04) 
compared to the ‘short’ group. Re-running of the multivariable Cox PH model for OS with the 
‘medium’ group of PRM as the reference category showed that ‘long’ PRM group had on average 3% 
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optimal PRM lay between 1.7 and 3cm irrespective of adjuvant treatment, disease grade, age at 
diagnosis and recurrence.    
In the multivariable analysis, in addition to the PRM, grade was a significant predictor for both DFS 
and OS.  Age was a significant predictor for OS only. Adjuvant treatment was associated with 
reduced disease free survival. 
 
Variable Disease-Free Survival1 Overall survival2 
HR (95% CI) P HR (95% CI) P 
Model (i) PRM with resection point at 1.7cm 
Proximal margin (cm)     
    Short (<1.7cm) 1.00  1.00  
    Long (≥1.7cm) 0.76 (0.41 – 1.39) 0.37 0.46 (0.25 – 0.87) 0.02 
Grade*  0.03  <0.001 
    I 1.00  1.00  
    II 2.24 (0.68 – 7.45) 0.19 4.25 (0.56 – 32.28) 0.16 
    III 3.20 (0.99 – 10.27) 0.05 8.90 (1.20 – 66.12) 0.03 
Adjuvant treatment     
    No 1.00  1.00  
    Yes 1.78 (1.15 – 2.76) 0.01 1.27 (0.77 – 2.12) 0.35 
Age at diagnosis  1.05 (1.02 – 1.08) 0.003 
Recurrence*  <0.001 
    No recurrence 1.00  
    Local recurrence 6.22 (3.17 – 12.19) <0.001 
    Distant recurrence 9.30 (4.99 – 17.33) <0.001 
 
Model (ii) PRM with two resection points at 1.7cm and 3.0cm 
Proximal margin (cm)*  0.60  0.09 
    Short (PRM<1.7cm) 1.00  1.00  
    Medium (1.7cm≤PRM≤3 cm) 0.68 (0.32 – 1.43) 0.30 0.45 (0.21 – 0.96) 0.04 
    Long (PRM>3 cm) 0.78 (0.42 – 1.44) 0.43 0.46 (0.25 – 0.89) 0.02 
Grade*  0.04  <0.001 
    I 1.00  1.00  
    II 2.22 (0.67 – 7.37) 0.19 4.23 (0.56 – 32.19) 0.16 
    III 3.15 (0.98 – 10.13) 0.06 8.87 (1.19 – 65.92) 0.03 
Adjuvant treatment     
    No 1.00  1.00  
    Yes 1.76 (1.13 – 2.73) 0.01 1.27 (0.76 – 2.12) 0.36 
Age at diagnosis  1.05 (1.02 – 1.08) 0.003 
Recurrence*  <0.001 
    No recurrence 1.00  
    Local recurrence 6.19 (3.15 – 12.19) <0.001 
    Distant recurrence 9.28 (4.97 – 17.31) <0.001 
Table 3. Multivariable survival analyses for all patients based on (i) PRM with one resection point at 1.7cm 
and (ii) PRM with two resection points at 1.7cm and 3.0cm  *Likelihood ratio test P-value to test for overall 
significance of the variable in the model; 1. Disease-free survival models adjusted for adjuvant treatment and grade of 






 Long Term Survival    
The 5-year OS for all patients was 44% and DFS was 37% (Table 4).  When the 5-year survival was 
analysed for the different resection point groups, the 5-year DFS and OS were highest for the 
patients with a ‘medium’ PRM (between 1.7cm and 3.0cm) at 48% and 57% respectively.  The 5-year 
OS rate for the ‘long’ group was slightly higher than that of the ‘short’ group in both the 2 group and 
3 group analysis.  
 5-year DFS  
Survival rate (95% CI) 
5-year OS  
Survival rate (95% CI) 
All patients 37% (0.29 - 0.45) 44% (0.35 - 0.52) 
   
i) 
Short (PRM<1.7cm), n=21 
 
33 (0.14 - 0.55) 
 
32% (0.12 - 0.54) 
Long (PRM≥1.7cm), n=153 37% (0.29 - 0.46) 45% (0.35 - 0.54) 
 
ii) 
Short (PRM<1.7cm), n=21 33% (0.14 - 0.55) 32% (0.12 - 0.54) 
Medium (PRM >1.7cm - ≤3.0cm), n=38 48% (0.30 - 0.64) 57% (0.40 - 0.71) 
Long (PRM>3.0cm), n=115 33% (0.24 - 0.43) 40% (0.28 - 0.51) 
Table 4. Five-year survival rate with 95% CI for all patients based on (i) PRM with on optimal resection point 




We present a large series assessing the significance of PRM in Ivor-Lewis oesophagectomy for 
cancer.  The importance of the circumferential and distal margins is well established. 5- 9   
Traditionally, long proximal resection margins have been advocated; we investigated whether those 
recommended in the literature were still relevant in contemporary practice.   
We have found through objective assessment that the optimum resection margin, in terms of 
disease free and overall survival, required for patients undergoing oesophagectomy lies between 1.7 
and 3 cm. A longer resection margin did not confer any advantage, but in fact was associated with 
reduced OS. 
Patient and tumour factors in our series were consistent with epidemiological data available in the 
literature.   Multivariable analysis demonstrated the age at diagnosis, administration of adjuvant 
treatment and increasing grade of the tumour were statistically significant factors for overall 
survival, which is consistent with other studies. 1,2, 24   
The single optimal PRM was determined to be 1.7cm, and the optimal range was between 1.7 and 
3cm.  In the analysis with either one or two resection points, a PRM less than 1.7cm adversely 
affected survival.  An involved margin carried a 46% higher risk of death as compared to a clear 
proximal resection margin.  There was a more profound effect of a PRM <1.7cm on OS as compared 




receive adjuvant chemo- or radiotherapy to treat residual disease following surgery. However, 
multivariable analysis demonstrated that adjuvant treatment adversely affected survival. This is 
likely to be a reflection of its use in involved margins and more aggressive disease. 
A PRM of greater than 1.7cm was found to be significant in improving OS, but there was a greater 
chance of survival with the ‘medium’ resection group as compared to the ‘long’ group.   Long-term 
(5-year) survival rates for the ‘medium’ group were highest. Additional analysis of the ‘medium’ PRM 
group as a reference (rather than the test cohort), illustrated a 3% increased hazards of death with a 
PRM >3cm. This indicates that a >3cm resection margin does not confer any further survival benefit, 
but may be associated with a slightly higher risk of mortality. There are several reasons for this 
which have been alluded to in other studies, in particular relating to post-operative and long term 
complications.16-18  
In this study, the anastomotic leak rates were the same across the ‘short’, ‘medium’ and ‘long’ 
groups . Given this finding, a further analysis was performed to assess why the long PRM group had a 
poorer outcome when compared to the medium group.  There was a higher proportion of Grade 3 
tumours in the ‘long’ group (65% versus 53% in the ‘medium’ group) and a greater proportion of T3 
and T4 tumours (60% versus 53%).  The nodal burden was also greater in the ‘long’ PRM group (19% 
N2 or N3, compared to 11% in the ‘medium’ PRM group) and the incidence of lymphovascular and 
perineural invasion was higher (51% and 40% versus 24% and 16% respectively).  These findings may 
aid the explanation of why the long PRM group had poorer outcomes than the medium group.  The 
rate of post-operative pulmonary complications was highest in the long PRM group (24.8%) 
compared to the short and medium group (17.4 and 18.4%).  This concurs with the literature which 
supports the finding of post-operative respiratory complications being more common with proximal 
anastomosis.25,26 The poorer survival for patients with longer resection margins is also likely to be 
because the longer resection margin is easily achieved for tumours of the gastroesophageal junction. 
These are known to have a poorer prognosis than tumours confined to the oesophagus.27 
During oesophagectomy, it may not be possible to attain the resection margins recommended in the 
literature.11,28 There may not be 4-5cm of oesophagus available in more proximal tumours.29 The 
mortality rate associated with an anastomotic leak is reportedly as high as 40%, highlighting the 
importance of a tension-free, vascularised and secure anastomosis.30  With trans-thoracic surgery, it 
is technically difficult to access the apex of the thorax and to construct a satisfactory anastomosis, 
necessitating a cervical anastomosis. The cervical approach is associated with increased morbidity, 
including potential damage to the laryngeal nerves.25 The incidence of anastomotic leakage and 
subsequent stenosis is higher in cervical anastomoses. This is probably due to the poorer blood 
supply to the proximal stomach which would be used for the anastomosis in the neck, but would be 
discarded in a thoracic anastomosis. There is also increased incidence of long term aspiration and 
respiratory complications.25,26  Also, the increasing practise of minimally invasive techniques, utilising 
a mini-thoracotomy in association with laparoscopic gastric mobilisation preclude anastomosis high 
in the thorax without extension of the thoracotomy incision.31,32  
Historically, a 10-12cm margin was recommended to ensure excision of intra-mural skip lesions.,10,11  
but these may be of reduced importance in modern practise. In the last decade, improved 
endoscopic techniques and higher resolution three-dimensional imaging have enabled improved 
accuracy and mapping of mucosal abnormalities.  Neo-adjuvant chemotherapy may have a role in 
controlling submucosal lymphatic spread.  Patient selection has changed; patients with a greater 
tumour burden may not be offered resection due to metastases identified by highly sensitive staging 
investigations.  Other studies have also found that a long PRM may not be warranted.  Barbour 
suggested a clearance of 3.8cm based on 352 oesopahagectomy specimens7 and Mariette 
recommended 7cm, although this study assessed only gastro-oesophageal junction tumours.33 
Another study assessing junctional tumours demonstrated that a PRM of 2cm was sufficient, with no 
further survival advantage achieved from more proximal resections 34 . In addition, Takubo described 
skip lesions at a distance of over 16cm from the primary tumour which would  not be encompassed 
by a long PRM.35 These tumours with distant intramural or lymphatic spread demonstrate a poorer 
prognosis  even if completely excised.36   
Of the 174 cases, 16 patients (9.2%) had microscopic positive resection margins, which is lower than 
the reported literature.12,13,33,34  This may relate to careful patient selection, the regular use of neo-
adjuvant treatment and  to our standard practise of resecting a generous cuff of crura and meso-
oesophageal tissue in continuity with the tumour reducing circumferential margin involvement.    
Another possible explanation for our low longitudinal resection margin involvement is the small 
number of squamous cell carcinomas (SCC) in our series (n=15; 8.6%). It is our usual practice to treat 
SCC with radical chemoradiotherapy, restricting resectional surgery for T1b tumours.  SCC are 
considered to demonstrate a higher incidence of submucosal extension and skip lesions which led to 
the original recommendations of long resection margins. Submucosal extension and skip lesions are 
associated with widespread lymphatic infiltration and likely lymphatic metastases. Current routine 
use of positron emission tomography will identify distant metastases which would not have been 
identified with historical imaging techniques. These patients would be excluded from resection.37,38. 
In the presence of accurate and detailed staging information, it has been suggested that localised 
tumours can be adequately treated with shorter resection margins.39 
In our series, only four (2.3%) patients developed an anastomotic recurrence despite a total of 
sixteen patients with involved margins.  This is lower than many other series and may be explained 
by the use of adjuvant chemoradiotherapy in cases with involved or close resection margins with low 
nodal burden. Also, as in other series it is likely that patients with microscopic involved margins had 
more biologically aggressive tumours and died of metastatic disease before clinical evidence of local 
recurrence became apparent .40,41 
Limitations 
There were a small number of cases in the short groups and those with involved resection margins, 
which may be responsible for some of the non significant results. Also, we included both squamous 
and adenocarcinoma of the oesophagus which may behave differently.  The high proportion of 
tumours with poor prognostic indicators in the long resection group may explain the poorer 
outcome in this group.  
Conclusion 
A proximal resection margin of greater than 1.7cm improved overall survival, but a PRM of >3cm did 
not yield a further survival advantage.  Thus, the optimal PRM for Ivor-Lewis oesophagectomy for 
cancer is likely to be between 1.7 and 3cm, regardless of confounding variables,: adjuvant 
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